AstraZeneca, Manchester Science Parks (MSP) pharmaceuticals news

AstraZeneca will sell its facility in Alderley Park, U.K., to MSP, a public-private science park operator. The pharma expects to complete the sale of the facility - which was focused on small molecule R&D - by the end of March, with the handover expected to take three years. The pharma said about 700 non-R&D roles will remain at the facility. The partners declined to disclose details. ...